Login / Signup
Tao Lu
ORCID
Publication Activity (10 Years)
Years Active: 2020-2024
Publications (10 Years): 3
Top Topics
Wild Type
Epithelial Mesenchymal Transition
Hepatitis B Virus
Clinical Practice
Top Venues
International journal of clinical pharmacy
Science advances
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yue Li
,
Mengdie Zhang
,
Yi Xu
,
Xin Li
,
Tao Lu
Availability, price, and affordability of anti-hepatitis B virus drugs: a cross-sectional study in China.
International journal of clinical pharmacy
46 (3) (2024)
Yue Li
,
Mengdie Zhang
,
Yi Xu
,
Xin Li
,
Tao Lu
Availability, price, and affordability of anti-hepatitis B virus drugs: a cross-sectional study in China.
International journal of clinical pharmacy
(2024)
Hong-Mei Li
,
Yan-Ran Bi
,
Yang Li
,
Rong Fu
,
Wen-Cong Lv
,
Nan Jiang
,
Ying Xu
,
Bo-Xue Ren
,
Ya-Dong Chen
,
Hui Xie
,
Shui Wang
,
Tao Lu
,
Zhao-Qiu Wu
A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer.
Science advances
6 (17) (2020)